| Pharm I - Part 3 |
anticoagulant, antiplatents |
Pharmacology |
2012-02-11 |
anguyen.2014 |
13 |
0 |
edit |
|
| Pharm I - Part 3.2 |
Antihyperlipidemic |
Pharmacology |
2012-02-11 |
anguyen.2014 |
19 |
0 |
edit |
|
| Pharm I - Part 3.3 |
Angina (prevent attacks, reduce cardiac workload) |
Unfinished |
2014-04-17 |
anguyen.2014 |
6 |
0 |
edit |
|
| Pharm I - Part 3.4 |
Cardiovascular |
Unfinished |
2012-02-11 |
anguyen.2014 |
20 |
0 |
edit |
|
| Pharm I - Part 3.5 |
Analgeisc |
Unfinished |
2012-02-11 |
anguyen.2014 |
15 |
0 |
edit |
|
| Pharm I - Part 3.6 |
Migraine |
Unfinished |
2012-02-11 |
anguyen.2014 |
1 |
0 |
edit |
|
| Pharm I - Part 3.7 |
Anti- Inflammatory |
Unfinished |
2012-02-11 |
anguyen.2014 |
3 |
0 |
edit |
|
| Pharm I - Part 3.8 |
Corticosteroids |
Unfinished |
2012-02-11 |
anguyen.2014 |
13 |
0 |
edit |
|
| Pharm I - Part 3 Gen |
General categories/effects of drugs |
Unfinished |
2012-02-11 |
anguyen.2014 |
4 |
0 |
edit |
|
| Pharm I - Part 3.9 |
Skeletal Muscle Relaxants |
Unfinished |
2012-02-11 |
anguyen.2014 |
4 |
0 |
edit |
|
| Pharm 3.10 |
Anticonvulsants |
Unfinished |
2012-02-12 |
anguyen.2014 |
12 |
0 |
edit |
|
| Pharm I 3.11 |
Parkinsonism, Movement Disorders |
Unfinished |
2012-02-12 |
anguyen.2014 |
8 |
0 |
edit |
|
| Pharm I Part 3.12 |
Antihistamines |
Unfinished |
2012-02-12 |
anguyen.2014 |
12 |
0 |
edit |
|
| Pharm I Part 3.13 |
Anemia |
Unfinished |
2012-02-12 |
anguyen.2014 |
12 |
0 |
edit |
|
| Pharm I Part 3.14 |
Psychiatric |
Unfinished |
2012-02-12 |
anguyen.2014 |
19 |
0 |
edit |
|
| Pharm I Part 2 |
Pharm I Part 2 |
Unfinished |
2012-11-12 |
anguyen.2014 |
137 |
1 |
edit |
|
| Pharm I part 3.15 |
Insomina, Anxiety, ADD |
Unfinished |
2012-02-13 |
anguyen.2014 |
13 |
0 |
edit |
|
| Pharm I Part 3.15 |
Gastrointestinal |
Unfinished |
2012-02-13 |
anguyen.2014 |
17 |
0 |
edit |
|
| Ocular |
Approach to Pharmacotherapy |
Unfinished |
2012-03-10 |
anguyen.2014 |
21 |
0 |
edit |
|
| Ocular p 10-26 |
Pregnancy and Lactation |
Unfinished |
2012-03-10 |
anguyen.2014 |
51 |
0 |
edit |
|
| Ocular Pharm pg27-29 |
Special Patient Populations and Needs |
Unfinished |
2012-03-20 |
anguyen.2014 |
11 |
0 |
edit |
|
| Ocular Pharm pg30-37 |
Ocular Tissue Structures and Pharmacokinetics |
Unfinished |
2012-04-09 |
anguyen.2014 |
37 |
0 |
edit |
|
| Ocular p. 38-46 |
Formulation, Administration, Delivery |
Unfinished |
2012-03-31 |
anguyen.2014 |
83 |
0 |
edit |
|
| Ocular- Top 200 |
Brand name (generic name)..... sux.... |
Unfinished |
2024-02-06 |
anguyen.2014 |
80 |
1 |
edit |
|
| Ocular pg47-50 |
Prescribing, Regulatory, and Legal Isssues |
Unfinished |
2012-04-09 |
anguyen.2014 |
12 |
0 |
edit |
|
| ocular pg51-54 |
Dyes |
Unfinished |
2012-04-09 |
anguyen.2014 |
15 |
0 |
edit |
|
| ocular pg68-71 |
mydriatics and cycloplegics |
Unfinished |
2012-04-10 |
anguyen.2014 |
18 |
0 |
edit |
|
| ocular pg72-top 76 |
antiallergy and decongestants |
Unfinished |
2012-04-10 |
anguyen.2014 |
44 |
0 |
edit |
|